Sort by
Refine Your Search
-
Category
-
Field
-
to contribute to a high-impact multi-centre study, funded by AstraZeneca, aiming to improve the timely diagnosis and management of transthyretin cardiac amyloidosis (ATTR-CA) through a streamlined referral
-
Associate in collaboration between AstraZeneca and Queen Mary University of London (QMUL) within the domain of Artificial Intelligence for multimodal integration of multi-omics and imaging data. About the
-
Partnership project in the Centre for Nanotechnology in Medicine. This role offers an exciting opportunity to contribute to next-generation nanotherapeutic strategies at the interface of neuro-oncology, drug
-
wide-ranging and multi-disciplinary approaches to take a ‘molecule to behaviour’ approach to understand, validate and then translate therapeutic opportunities by targeting trans-plasma membrane and